News Atai & Beckley Psychedelic Merger Creates Global Mental Health Leader Atai Life Sciences and Beckley Psytech are merging in an all-stock transaction, creating atai Beckley, a leading mental health... By Jon Napitupulu June 10, 2025 Read More
News Promising Data: Alrizomadlin in Solid Tumors Ascentage Pharma released Phase II clinical trial data for its MDM2-p53 inhibitor, alrizomadlin (APG-115), at the 2025 ASCO Annual... By Jon Napitupulu June 10, 2025 Read More
News RECELL Reduced Hospital Stays: Largest Real-World Analysis AVITA Medical highlighted data from the British Burn Association Annual Meeting showing that RECELL, its spray-on skin cell technology,... By Jon Napitupulu June 10, 2025 Read More
News Polypid’s Shield II Phase 3 Trial Delivers Groundbreaking Results PolyPid Ltd. announced positive topline results from its Phase 3 SHIELD II trial of D-PLEX100 for preventing surgical site... By Jon Napitupulu June 10, 2025 Read More
News Humacyte’s AV Access Study Shows Promising Results Humacyte, a biotech company focused on bioengineered human tissues, presented positive Phase 3 clinical trial results for their acellular... By Jon Napitupulu June 10, 2025 Read More
News Metsera Announces Positive Phase 1 Data of Amylin Candidate Metsera, Inc. announced positive Phase 1 clinical trial data for MET-233i, a new ultra-long-acting amylin analog designed for monthly... By Jon Napitupulu June 10, 2025 Read More
News Lisaftoclax Data in Venetoclax-Refractory Patients from ASCO 2025 Ascentage Pharma presented Phase Ib/II data at the 2025 ASCO Annual Meeting for lisaftoclax, a Bcl-2 inhibitor, combined with... By Jon Napitupulu June 9, 2025 Read More
News Ziftomenib Monotherapy Shows Positive Pivotal Data at ASCO 2025 Kura Oncology and Kyowa Kirin announced positive Phase 2 trial results for ziftomenib, an oral menin inhibitor, in patients... By Jon Napitupulu June 9, 2025 Read More
News Onvansertib and Paclitaxel Show Promising Results in Metastatic TNBC Cardiff Oncology announced positive data from a Phase 1b clinical trial of onvansertib combined with paclitaxel for metastatic triple-negative... By Jon Napitupulu June 9, 2025 Read More
News 4D Path Biomarker Predicts Breast Cancer Treatment Response 4D Path presented groundbreaking findings at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting, demonstrating that their... By Jon Napitupulu June 9, 2025 Read More